Division of Pulmonary and Critical Care, University of Maryland School of Medicine, Baltimore, MD.
University of Rochester School of Medicine and Dentistry, Rochester, NY.
Crit Care Explor. 2024 Oct 21;6(10):e1166. doi: 10.1097/CCE.0000000000001166. eCollection 2024 Oct.
Extracorporeal membrane oxygenation (ECMO) is often withheld in patients with significant neurologic injury or recent neurosurgical intervention due to perceived futility. Studies of neurosurgical interventions before or during ECMO are limited to case reports or single-center series, limiting generalizability, and outcomes in this population are unknown. We therefore sought to report the outcomes of ECMO patients with acute neurosurgical interventions at four high-volume ECMO and comprehensive stroke centers.
Retrospective case series.
Four academic tertiary referral hospitals in the United States.
Adults ( = 24) having undergone neurosurgical procedures before or during ECMO.
None.
We retrospectively reviewed adults at four institutions who had undergone neurosurgical procedures immediately before or during ECMO from 2015 to 2023. The primary outcome was survival to hospital discharge. Secondary outcomes included favorable neurologic outcome (Cerebral Performance Category 1 or 2) and neurosurgical complications. Twenty-four of 2957 ECMO patients (0.8%) were included. Primary indications for neurosurgical intervention included traumatic brain ( = 8) or spinal ( = 3) injury, spontaneous intracranial hemorrhage ( = 6), and acute ischemic stroke ( = 5). Procedures included extraventricular drain (EVD) and/or intracranial pressure monitor placement ( = 10), craniectomy/craniotomy ( = 5), endovascular thrombectomy ( = 4), and spinal surgery ( = 3). Fifteen patients (63%) survived to hospital discharge, of whom 12 (80%) were discharged with favorable neurologic outcomes. Survival to discharge was similar for venoarterial and venovenous ECMO patients (8/12 vs. 7/12; = 0.67) and those who had neurosurgery before vs. during ECMO (8/13 vs. 7/11; = 0.92). One patient (4%) experienced a neurosurgical complication, a nonlethal tract hemorrhage from EVD placement. Survival to discharge was similar for neurosurgical and nonneurosurgical ECMO patients at participating institutions (63% vs. 57%; = 0.58).
Patients with acute neurologic injury can feasibly undergo neurosurgery during ECMO or can undergo ECMO after recent neurosurgery. Larger studies are needed to fully understand risks for bleeding and other procedure-related complications.
由于认为没有希望,体外膜肺氧合(ECMO)常被用于有严重神经损伤或近期神经外科干预的患者。在 ECMO 之前或期间进行神经外科干预的研究仅限于病例报告或单中心系列研究,限制了其普遍性,并且该人群的结果尚不清楚。因此,我们旨在报告在四家高容量 ECMO 和综合卒中中心进行急性神经外科干预的 ECMO 患者的结果。
回顾性病例系列。
美国四家学术三级转诊医院。
接受过神经外科手术的成年人(= 24 人)在 ECMO 之前或期间。
无。
我们回顾性地审查了四家机构的成年人,他们在 2015 年至 2023 年期间在 ECMO 之前或期间接受了神经外科手术。主要结局是存活至出院。次要结局包括良好的神经功能结局(Cerebral Performance Category 1 或 2)和神经外科并发症。2957 名 ECMO 患者中有 24 名(0.8%)被纳入。神经外科干预的主要指征包括创伤性脑(= 8)或脊髓(= 3)损伤、自发性颅内出血(= 6)和急性缺血性卒中(= 5)。手术包括脑室引流(EVD)和/或颅内压监测放置(= 10)、开颅术/颅骨切开术(= 5)、血管内血栓切除术(= 4)和脊柱手术(= 3)。15 名患者(63%)存活至出院,其中 12 名(80%)出院时神经功能良好。静脉动脉和静脉静脉 ECMO 患者(8/12 对 7/12;= 0.67)以及在 ECMO 之前或期间接受神经外科手术的患者(8/13 对 7/11;= 0.92)的出院生存率相似。1 名患者(4%)发生神经外科并发症,EVD 放置后非致命性的引流管出血。参与机构的神经外科和非神经外科 ECMO 患者的出院生存率相似(63%对 57%;= 0.58)。
患有急性神经损伤的患者可以在 ECMO 期间进行神经外科手术,也可以在近期神经外科手术后进行 ECMO。需要更大的研究来充分了解出血和其他与手术相关的并发症的风险。